NASDAQ:JAGX

Jaguar Health (JAGX) Stock Forecast, Price & News

$0.66

-0.01 (-1.50%)

(As of 06/8/2023 ET)

Compare

Today's Range: $0.64
▼
$0.68
50-Day Range: $0.48
▼
$0.98
52-Week Range: $0.46
▼
$28.50

Volume: 369,963 shs
Average Volume: 2.29 million shs
Market Capitalization: $9.08 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Jaguar Health (NASDAQ:JAGX) Stock

Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer, which is in Phase 3 clinical trial for or prophylaxis of diarrhea in adult cancer patients, and to address rare/orphan disease indications, including Short bowel syndrome with intestinal failure and/or congenital diarrheal disorders; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops NP-300, a second-generation proprietary anti-secretory antidiarrheal drug for symptomatic relief and treatment of moderate-to-severe diarrhea; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. The company was founded in 2013 and is headquartered in San Francisco, California.

Receive JAGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jaguar Health and its competitors with MarketBeat's FREE daily newsletter.

JAGX Stock News Headlines

June 8, 2023 | finanznachrichten.de

Jaguar Health, Inc.: Canine and Child Cancer Research Advocates Call for Support as Capitol Hill "Goes to the Dogs"

June 8, 2023 | finance.yahoo.com

Canine and Child Cancer Research Advocates Call for Support as Capitol Hill "Goes to the Dogs"

June 8, 2023 | Legacy Research (Affiliate) (Ad)

Sell Every Stock, Except ONE (Ticker Revealed)

We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.

June 7, 2023 | finance.yahoo.com

European Pharmaceutical Industry Leader and Entrepreneur Massimo Radaelli, PhD Named Commander of the Italian Republic for Special Merits

May 30, 2023 | americanbankingnews.com

Jaguar Health (NASDAQ:JAGX) Lowered to "Sell" at StockNews.com

May 25, 2023 | finanznachrichten.de

Jaguar Health, Inc.: Take C.H.A.R.G.E. Registry Marks One-Year Anniversary on National Canine Cancer Awareness Day, With Database Grown 40%

May 24, 2023 | finanznachrichten.de

Jaguar Health, Inc.: Board Certified Patient Advocate Stacey Tinianov, MPH, Joins Jaguar Health's Scientific Advisory Board

May 24, 2023 | finance.yahoo.com

Board Certified Patient Advocate Stacey Tinianov, MPH, Joins Jaguar Health's Scientific Advisory Board

June 8, 2023 | Behind the Markets (Ad)

Laser breakthrough could send stock soaring 2,467%

Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...

May 23, 2023 | finance.yahoo.com

Take C.H.A.R.G.E. Registry Marks One-Year Anniversary on National Canine Cancer Awareness Day, With Database Grown 40%

May 22, 2023 | americanbankingnews.com

StockNews.com Upgrades Jaguar Health (NASDAQ:JAGX) to Hold

May 17, 2023 | finance.yahoo.com

Jaguar Health First Quarter 2023 Earnings: US$2.39 loss per share (vs US$30.17 loss in 1Q 2022)

May 16, 2023 | finanznachrichten.de

Jaguar Health, Inc.: Jaguar Health Reports First Quarter 2023 Financial Results

May 16, 2023 | finanznachrichten.de

Jaguar Health, Inc.: Jaguar Health to Present at Lytham Partners Spring 2023 Investor Conference & Participate in Animal Health Panel

May 16, 2023 | finance.yahoo.com

Jaguar Health to Present at Lytham Partners Spring 2023 Investor Conference & Participate in Animal Health Panel

May 16, 2023 | finance.yahoo.com

Q1 2023 Jaguar Health Inc Earnings Call

May 15, 2023 | markets.businessinsider.com

Here's what Wall Street expects from Jaguar Health's earnings report

May 15, 2023 | finance.yahoo.com

Jaguar Health Reports First Quarter 2023 Financial Results

May 14, 2023 | americanbankingnews.com

Jaguar Health (JAGX) Scheduled to Post Quarterly Earnings on Monday

May 13, 2023 | americanbankingnews.com

Jaguar Health (NASDAQ:JAGX) Upgraded at StockNews.com

May 12, 2023 | finance.yahoo.com

REMINDER: Jaguar Health to Hold Investor Webcast Monday, May 15th at 8:30 AM EDT Regarding Q1 2023 Financials & Corporate Updates

May 10, 2023 | finanznachrichten.de

Jaguar Health, Inc.: Jaguar Health Launches AI-powered Web Portal to Support Patient Access to Mytesi, the Company's FDA-approved Prescription Drug

May 10, 2023 | finance.yahoo.com

Jaguar Health Launches AI-powered Web Portal to Support Patient Access to Mytesi, the Company's FDA-approved Prescription Drug

May 9, 2023 | marketwatch.com

8-K: Jaguar Health, Inc.

May 9, 2023 | finance.yahoo.com

Jaguar Completes Enrollment in Its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea

May 8, 2023 | finance.yahoo.com

Jaguar Health to Hold Investor Webcast Monday, May 15th at 8:30 AM EDT Regarding Q1 2023 Financials & Corporate Updates

May 4, 2023 | americanbankingnews.com

StockNews.com Lowers Jaguar Health (NASDAQ:JAGX) to Sell

See More Headlines

JAGX Price History

30 days | 90 days | 365 days | Advanced Chart

JAGX Company Calendar

Last Earnings: 11/17/2021
Today: 6/08/2023
Next Earnings (Estimated): 8/28/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:JAGX
CUSIP: N/A
CIK: 1585608
Web: www.jaguaranimalhealth.com
Phone: (415) 371-8300
Fax: N/A
Employees: 60
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-47,450,000.00
Net Margins: -368.66%
Pretax Margin: -377.14%
Return on Equity: -1,337.16%
Return on Assets: -82.36%

Debt

Debt-to-Equity Ratio: 2.29
Current Ratio: 1.04
Quick Ratio: 0.76

Sales & Book Value

Annual Sales: $11.96 million
Price / Sales: 0.77
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.32) per share
Price / Book: -2.09

Miscellaneous

Outstanding Shares: 13,860,000
Free Float: 13,840,000
Market Cap: $9.25 million
Optionable: Not Optionable
Beta: 1.82

Key Executives

Ms. Lisa A. Conte (Age 64)
Founder, CEO, Pres & Director
Comp: $771.4k

Dr. Pravin R. Chaturvedi Ph.D. (Age 60)
Chief Scientific Officer & Chair of Scientific Advisory Board
Comp: $539.04k

Mr. Jonathan S. Wolin CPA (Age 60)
J.D., M.B.A., Chief of Staff, Chief Compliance Officer & Gen. Counsel
Comp: $520.29k

Mr. Ian H. Wendt M.B.A. (Age 55)
Chief Commercial Officer
Comp: $441.31k

Dr. Steven R. King Ph.D. (Age 65)
Chief of Sustainable Supply, Ethnobotanical Research & Intellectual Property and Sec.
Comp: $477.66k

Ms. Carol R. Lizak M.B.A. (Age 59)
Chief Financial Officer

Mr. Peter Hodge
Sr. Director of Investor Relations, Bus. Devel. & Special Events

Dr. Karen J. Brunke Ph.D. (Age 70)
Exec. VP of Corp. & Bus. Devel.

Mr. David Sesin
Chief Manufacturing Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

JAGX Stock - Frequently Asked Questions

How have JAGX shares performed in 2023?: Jaguar Health's stock was trading at $0.0869 on January 1st, 2023. Since then, JAGX stock has increased by 668.1% and is now trading at $0.6675.
View the best growth stocks for 2023 here.
Are investors shorting Jaguar Health?: Jaguar Health saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 2,950,000 shares, an increase of 163.4% from the April 30th total of 1,120,000 shares. Based on an average daily volume of 3,550,000 shares, the short-interest ratio is presently 0.8 days.
View Jaguar Health's Short Interest.
When is Jaguar Health's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, August 28th 2023.
View our JAGX earnings forecast.
How were Jaguar Health's earnings last quarter?: Jaguar Health, Inc. (NASDAQ:JAGX) issued its quarterly earnings results on Wednesday, November, 17th. The biotechnology company reported ($0.27) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.18) by $0.09. The biotechnology company had revenue of $0.63 million for the quarter. Jaguar Health had a negative trailing twelve-month return on equity of 1,337.16% and a negative net margin of 368.66%. During the same quarter last year, the business posted ($0.63) earnings per share.
When did Jaguar Health's stock split?: Jaguar Health shares reverse split before market open on Wednesday, September 8th 2021. The 1-3 reverse split was announced on Wednesday, September 8th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, September 8th 2021. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.
What other stocks do shareholders of Jaguar Health own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Jaguar Health investors own include Biocept (BIOC), Sorrento Therapeutics (SRNE), Trevena (TRVN), Vaxart (VXRT), Purple Biotech (KTOV), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Biopharmx (BPMX), Cara Therapeutics (CARA) and Conatus Pharmaceuticals (CNAT).

When did Jaguar Health IPO?: (JAGX) raised $22 million in an IPO on Wednesday, May 13th 2015. The company issued 3,200,000 shares at $7.00 per share. Aegis Capital Corp acted as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers.
What is Jaguar Health's stock symbol?: Jaguar Health trades on the NASDAQ under the ticker symbol "JAGX."
Who are Jaguar Health's major shareholders?: Jaguar Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Acadian Asset Management LLC (0.50%), Two Sigma Securities LLC (0.37%), BlackRock Inc. (0.37%) and Simplex Trading LLC (0.00%).
View institutional ownership trends.
How do I buy shares of Jaguar Health?: Shares of JAGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Jaguar Health's stock price today?: One share of JAGX stock can currently be purchased for approximately $0.67.
How much money does Jaguar Health make?: Jaguar Health (NASDAQ:JAGX) has a market capitalization of $9.25 million and generates $11.96 million in revenue each year.
How can I contact Jaguar Health?: Jaguar Health's mailing address is 201 MISSION STREET SUITE 2375, SAN FRANCISCO CA, 94105. The official website for the company is www.jaguaranimalhealth.com. The biotechnology company can be reached via phone at (415) 371-8300.

This page (NASDAQ:JAGX) was last updated on 6/8/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial